CLINICAL_TRIALS
trial_result
· 2015-03-26
Clinical Trial Update: Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) [Phase 4]
Summary
A Phase 4 clinical trial update on metformin for nonalcoholic fatty liver disease (NAFLD) shows the study was terminated with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Fatty Liver | Phase 4 | Status: TERMINATED | Results posted: 2015-03-26